Adoptive Immunotherapy Following Umbilical Cord Blood Transplantation Using The Sleeping Beauty System and Artificial Antigen Presenting Cells To Generate Donor-Derived T Cells Expressing a CD19-Specific Chimeric Antigen Receptor

被引:0
|
作者
Kebriaei, Partow
Huls, Helen
Singh, Harjeet
Olivares, Simon
Figliola, Matthew
Kumar, Pappanaicken R.
Jena, Bipulendu
Jackson, Rineka N.
Liu, Tingting
McNiece, Ian K.
Rondon, Gabriela
Hackett, Perry
Champlin, Richard E.
Shpall, Elizabeth J.
Cooper, Laurence J. N.
机构
关键词
D O I
10.1182/blood.V122.21.4208.4208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4208
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Adoptive Therapy Using Sleeping Beauty Gene Transfer System and Artificial Antigen Presenting Cells to Manufacture T Cells Expressing CD19-Specific Chimeric Antigen Receptor
    Kebriaei, Partow
    Huls, Helen
    Singh, Harjeet
    Olivares, Simon
    Figliola, Matthew
    Maiti, Sourindra
    Su Shihuang
    Kumar, Pappanaicken R.
    Jena, Bipulendu
    Forget, Marie Andree
    Ang, Sonny
    Rineka, Jackson
    Liu, Tingting
    McNiece, Ian K.
    Rondon, Gabriela
    Hackett, Perry
    Wierda, William G.
    O'Brien, Susan
    Keating, Michael J.
    Kantarjian, Hagop M.
    Hosing, Chitra M.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Cooper, Laurence J. N.
    BLOOD, 2014, 124 (21)
  • [2] FIRST CLINICAL TRIALS EMPLOYING SLEEPING BEAUTY SYSTEM AND ARTIFICIAL ANTIGEN PRESENTING CELLS TO GENERATE T CELLS EXPRESSING CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
    Kebriaei, P.
    Huls, H.
    Singh, H.
    Olivares, S.
    Figliola, M.
    Dawson, M.
    Jena, B.
    Jackson, R.
    Bosque, D.
    Rondon, G.
    McNiece, I.
    Hackett, P.
    Shpall, E.
    Champlin, R.
    Cooper, L.
    HAEMATOLOGICA, 2013, 98 : 489 - 490
  • [3] Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells
    Singh, Harjeet
    Figliola, Matthew J.
    Dawson, Margaret J.
    Olivares, Simon
    Zhang, Ling
    Yang, Ge
    Maiti, Sourindra
    Manuri, Pallavi
    Senyukov, Vladimir
    Jena, Bipulendu
    Kebriaei, Partow
    Champlin, Richard E.
    Huls, Helen
    Cooper, Laurence J. N.
    PLOS ONE, 2013, 8 (05):
  • [4] Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor
    H Singh
    J S E Moyes
    M H Huls
    L J N Cooper
    Cancer Gene Therapy, 2015, 22 : 95 - 100
  • [5] Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor
    Singh, H.
    Moyes, J. S. E.
    Huls, M. H.
    Cooper, L. J. N.
    CANCER GENE THERAPY, 2015, 22 (02) : 95 - 100
  • [6] First Clinical Trials Employing Sleeping Beauty Gene Transfer System and Artificial Antigen Presenting Cells To Generate and Infuse T Cells Expressing CM19-Specific Chimeric Antigen Receptor
    Kebriaei, Partow
    Huls, Helen
    Singh, Harjeet
    Olivares, Simon
    Figliola, Matthew
    Kumar, Pappanaicken R.
    Jena, Bipulendu
    Forget, Marie Andree
    Ang, Sonny
    Jackson, Rineka N.
    Liu, Tingting
    Bosque, Doyle
    McNiece, Ian K.
    Rondon, Gabriela
    Hackett, Perry
    Hosing, Chitra M.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Cooper, Laurence J. N.
    BLOOD, 2013, 122 (21)
  • [7] Donor-derived CD19 chimeric antigen receptor T cells
    Singh, Nathan
    Barrett, David M.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 503 - 508
  • [8] Artificial antigen presenting cell can be used to propagate genetically modified CD19-specific T cells through chimeric antigen receptor.
    Numbenjapon, T
    Serrano, LMA
    Olivares, S
    Chang, WC
    Singh, H
    Kowolik, CM
    Gonzalez, S
    Gonzalez, N
    Cooper, LJN
    BLOOD, 2005, 106 (11) : 377A - 377A
  • [9] Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
    Huls, M. Helen
    Figliola, Matthew J.
    Dawson, Margaret J.
    Olivares, Simon
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Singh, Harjeet
    Cooper, Laurence J. N.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (72):
  • [10] Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
    Kebriaei, Partow
    Singh, Harjeet
    Huls, M. Helen
    Figliola, Matthew J.
    Bassett, Roland
    Olivares, Simon
    Jena, Bipulendu
    Dawson, Margaret J.
    Kumaresan, Pappanaicken R.
    Su, Shihuang
    Maiti, Sourindra
    Dai, Jianliang
    Moriarity, Branden
    Forget, Marie-Andree
    Senyukov, Vladimir
    Orozco, Aaron
    Liu, Tingting
    McCarty, Jessica
    Jackson, Rinelca N.
    Moyes, Judy S.
    Rondon, Gabriela
    Qazilbash, Muzaffar
    Ciurea, Stefan
    Alousi, Amin
    Nieto, Yago
    Rezvani, Katy
    Marin, David
    Popat, Uday
    Hosing, Chitra
    Shpall, Elizabeth J.
    Kantarjian, Hagop
    Keating, Michael
    Wierda, William
    Do, Kim Anh
    Largaespada, David A.
    Lee, Dean A.
    Hackett, Perry B.
    Champlin, Richard E.
    Cooper, Laurence J. N.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09): : 3363 - 3376